↓ Skip to main content

PLOS

A New Parameterized Algorithm for Rapid Peptide Sequencing

Overview of attention for article published in PLOS ONE, February 2014
Altmetric Badge

Mentioned by

twitter
6 X users
reddit
1 Redditor

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
8 Mendeley
Title
A New Parameterized Algorithm for Rapid Peptide Sequencing
Published in
PLOS ONE, February 2014
DOI 10.1371/journal.pone.0087476
Pubmed ID
Authors

Yinglei Song

Abstract

De novo sequencing is an important computational approach to determining the amino acid sequence of a peptide with tandem mass spectrometry (MS/MS). Most of the existing approaches use a graph model to describe a spectrum and the sequencing is performed by computing the longest antisymmetric path in the graph. The task is often computationally intensive since a given MS/MS spectrum often contains noisy data, missing mass peaks, or post translational modifications/mutations. This paper develops a new parameterized algorithm that can efficiently compute the longest antisymmetric partial path in an extended spectrum graph that is of bounded path width. Our testing results show that this algorithm can efficiently process experimental spectra and provide sequencing results of high accuracy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 13%
Unknown 7 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 50%
Student > Ph. D. Student 1 13%
Student > Doctoral Student 1 13%
Student > Master 1 13%
Unknown 1 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 50%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Computer Science 1 13%
Chemistry 1 13%
Engineering 1 13%
Other 0 0%